Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021
OBJETIVO GENERAL Determinar las manifestaciones clínicas posagudas y nivel de calidad de vida a 6 meses en pacientes atendidos por COVID-19 en el Hospital General de Barranquilla, durante el periodo de enero a julio de 2021. METODOLOGÍA Estudio descriptivo, longitudinal, prospectivo. Los datos fuero...
- Autores:
-
Castellón De La Rosa, Evis Adriana
Jiménez Arcia, Luisa Fernanda
- Tipo de recurso:
- Fecha de publicación:
- 2022
- Institución:
- Universidad Libre
- Repositorio:
- RIU - Repositorio Institucional UniLibre
- Idioma:
- OAI Identifier:
- oai:repository.unilibre.edu.co:10901/23839
- Acceso en línea:
- https://hdl.handle.net/10901/23839
- Palabra clave:
- COVID 19
Manifestaciones posagudas
Calidad de vida
Factores de riesgo
COVID 19
Post-acute manifestations
Quality of life
Risk factors
Infecciones por coronavirus
Calidad de vida
Signos y síntomas
- Rights
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| id |
RULIBRE2_7c68c1da78903da50339e85cddace661 |
|---|---|
| oai_identifier_str |
oai:repository.unilibre.edu.co:10901/23839 |
| network_acronym_str |
RULIBRE2 |
| network_name_str |
RIU - Repositorio Institucional UniLibre |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 |
| title |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 |
| spellingShingle |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 COVID 19 Manifestaciones posagudas Calidad de vida Factores de riesgo COVID 19 Post-acute manifestations Quality of life Risk factors Infecciones por coronavirus Calidad de vida Signos y síntomas |
| title_short |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 |
| title_full |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 |
| title_fullStr |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 |
| title_full_unstemmed |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 |
| title_sort |
Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021 |
| dc.creator.fl_str_mv |
Castellón De La Rosa, Evis Adriana Jiménez Arcia, Luisa Fernanda |
| dc.contributor.advisor.none.fl_str_mv |
Zuluaga De León, Iván Navarro Baene, Gina |
| dc.contributor.author.none.fl_str_mv |
Castellón De La Rosa, Evis Adriana Jiménez Arcia, Luisa Fernanda |
| dc.subject.spa.fl_str_mv |
COVID 19 Manifestaciones posagudas Calidad de vida Factores de riesgo |
| topic |
COVID 19 Manifestaciones posagudas Calidad de vida Factores de riesgo COVID 19 Post-acute manifestations Quality of life Risk factors Infecciones por coronavirus Calidad de vida Signos y síntomas |
| dc.subject.subjectenglish.spa.fl_str_mv |
COVID 19 Post-acute manifestations Quality of life Risk factors |
| dc.subject.lemb.spa.fl_str_mv |
Infecciones por coronavirus Calidad de vida Signos y síntomas |
| description |
OBJETIVO GENERAL Determinar las manifestaciones clínicas posagudas y nivel de calidad de vida a 6 meses en pacientes atendidos por COVID-19 en el Hospital General de Barranquilla, durante el periodo de enero a julio de 2021. METODOLOGÍA Estudio descriptivo, longitudinal, prospectivo. Los datos fueron obtenidos del Hospital General de Barranquilla y el seguimiento a 6 meses se realiza— por vía telefónica mediante encuesta de síntomas y escala SF12. El análisis se hizo mediante el programa SPSS en su versión 15. Se emplearon medidas descriptivas para el análisis univariado: porcentaje y promedio y desviación estándar. Para el análisis bivariado se emplea— prueba t.Ê RESULTADOS De 16 manifestaciones clínicas postagudas descritas en la literatura, la disnea y la fatiga, fueron las más frecuentes, con 42,2% y 41,3%, respectivamente, el resto de las manifestaciones estuvieron entre 13,9% y 28,3%. El resultado de los componentes de salud física y salud mental, según el SF-12, muestran que, en ninguno de los casos el promedio llega a 50 puntos, siendo más bajo para salud física (Prom: 38,1 +/-5,5). ??Al comparar los promedios de salud física y emocional según las variables sociodemográficas, se encontraron diferencias significativas (p<0,05) para el sexo (mayor puntaje en hombres) en salud física y para el estrato (mayor puntaje en el estrato dos) en salud mental. Al relacionar los promedios de las dimensiones salud física y salud mental según cada una de las manifestaciones clínicas postagudas, no se encontraron diferencias significativas en ninguno de los casos, con excepción—n del dolor torácico en la primera dimensión. CONCLUSIONES La dificultad respiratoria y la fatiga fueron las manifestaciones más frecuentes. Los puntajes del SF-12 tanto para el componente de salud física como para el de salud mental fueron relativamente bajos en la mayoría de los participantes, por lo que solamente se encontraron diferencias significativas al cruzar salud física con sexo y salud mental con estrato socioeconómico, para el caso de las variables sociodemográficas. Para las manifestaciones clínicas postagudas no hubo diferencias significativas entre los que las padecían y los que no. |
| publishDate |
2022 |
| dc.date.accessioned.none.fl_str_mv |
2022-12-05T20:27:53Z |
| dc.date.available.none.fl_str_mv |
2022-12-05T20:27:53Z |
| dc.date.created.none.fl_str_mv |
2022 |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_7a1f |
| dc.type.local.spa.fl_str_mv |
Tesis de Especialización |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10901/23839 |
| url |
https://hdl.handle.net/10901/23839 |
| dc.relation.references.spa.fl_str_mv |
Who.int (Internet). Estados Unidos: Whoint; 2000 [actualizado 06 de noviembre 2020; citado 1 de noviembre de 2020. Tomado de: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public Fecha de acceso: febrero de 2021 Coronavirus.jhu.edu. Estados Unidos: coronavirus.jhu.edu; 2020. Tomado de: https://coronavirus.jhu.edu/map.html Fecha de acceso: febrero de 2021 Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of postacute COVID-19 in primary care. BMJ. 2020;370:m3026 Del Rio C, Collins L, Malani P. Long-term health consequences of COVID19. Jama, 2020; 324(17): 1723-1724 Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, Zhou X et al. Impact of Coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020; 21:163 Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID -19. JAMA. 2020; 324(6):603-605 Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. The Lancet, 2020; 395(10224): e37-e38 Xu Z, Li S, Tian S, Li H, Kong L. Full spectrum of COVID-19 severity still being depicted. Lancet, 2020; 395(10228): 947 Jack A. Why the panic? South Korea’s MERS response questioned. Bmj, 2015; 350(1): h3403 Abdel-Moneim A. Middle East respiratory syndrome coronavirus: Is it worth a world panic? World journal of virology, 2015; 4(3): 185-187 Brooks S, Webster R, Smith L, Woodland L, Wessely S, Greenberg N, Rubin G. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet, 2020; 395(10227): P912-P920 Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-Related Quality of Life and its Associated Factors in. COVID-19 Patients. Osong Public Health Res Perspect 2020;11(5):296-302 Piedra J, Cuellar C, Machado V. Instrumentos evaluadores de secuelas en pacientes postinfección a COVID-19. Su utilidad en rehabilitación. Revista Cubana de Medicina Física y Rehabilitación, 2020; 12(3): 1-22 Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay, 2020; 10(2): 78-88 Maley J, Brewster I, Mayoral I, Siruckova R, Adams S, McGraw K, Mikkelsen M. Resilience in survivors of critical illness in the context of the survivors’ experience and recovery. Ann Am Thorac Soc. 2016;13(8):1351-1360 Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA, 2020;324(6):603-605 Tenforde M, Kim S, Lindsell C y cols.; IVY Network Investigators; CDC COVID19 Response Team; IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network: United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998 Caliari D, Campos K, Dos Santos P, Louro S, Curty T, Mendanha T, Dos Reis E. Associação entre las características sociodemográficas y síntomas da COVID-19 em pacientes residentes do Espírito Santo, Brasil: Association between the sociodemographic characteristics and COVID-19 symptoms in patients resident in Espírito Santo state, Brazil. Health and Biosciences, 2020; 1(2): 32-51 Instituto Nacional de Salud. Coronavirus. Tomado de: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx Fecha de acceso: febrero de 2021 Rothan H, Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity, 2020; 109(1): 102433 Puntmann V, Carerj M, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3557 Rajpal S, Tong M, Borchers J, Zareba K, Obarski T, Simonetti O, Daniels C. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA cardiology, 2021; 6(1): 116-118 Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, Luo H. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine, 2020; 25(1): 100463 Zubair A, McAlpine L, Gardin T, Farhadian S, Kuruvilla D, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018-1027 Galea S, Merchant R, Lurie N. The mental health consequences of COVID19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020;180(6):817-818 Ware J, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical care, 1996; 34(1): 220-233 Cleaton N, Raizada S, Barkham N, Venkatachalam S, Sheeran T, Adizie T, Bateman J. COVID-19 prevalence and the impact on quality of life from stringent social distancing in a single large UK rheumatology centre. Annals of the Rheumatic Diseases, 2021; 80(6): e93-e93 Liu C, Stevens C, Conrad R, Hahm H. Evidence for elevated psychiatric distress, poor sleep, and quality of life concerns during the COVID-19 pandemic among US young adults with suspected and reported psychiatric diagnoses. Psychiatry research, 2020; 292(1): 113345 Di Stefano V, Battaglia G, Giustino V, Gagliardo A, D’Aleo M, Giannini O, Brighina F. Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine. Journal of neurology, 2020; 1(1): 1-7 Walline J. COVID -19- Quality of Life After Infection. Clinical Trials. gov: NCT04377464. Chinese University of Hong Kong. 2020. disponible en https://clinicaltrials.gov/ct2/show/NCT04377464#contacts Saavedra C, Buitrago A, Jiménez A, Mejía A, Narváez A, Rojas A, et al. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud. Infectio. 2020; 24 (3):1-153 Maréchal M, Morand P, Epaulard O, Némoz B. COVID-19 in clinical practice: a narrative synthesis. Med Mal Infect, 2020; 50(20): 30710-1 Gordon D, Jang G, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARSCoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; 583 Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020;2 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181:271-280.e8 Chan J, Yuan S, Kok K, Wang K, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. Lancet. 2020; 395: 514–23 Lei J, Li J, Li X, Qi X. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 2020; 295(1): 18-18 Lu H. Drug treatment options for the 2019-new coronavirus (2019- nCoV). Bioscience trends, 2020;14(1): 69-71 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020; 395(10223): 497-506 Luo W, Yu H, Gou J, Li X, Sun Y, Li J, Liu L. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints, 2020: 2020020407 Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon D, Van Tassell B, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nature Reviews Immunology, 2021; 21(5): 319- 329 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Xing X. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 2020; 382(1):1199-1207 Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol, 2020; 92(4): 441– 447 Carlos W, Dela Cruz C, Cao B, Pasnick S, Jamil S. Novel wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med, 2020; 201(4): 7–8 Assiri A, Al-Tawfiq J, Al-Rabeeah A, Al-Rabiah F, Al-Hajjar S, Al-Barrak A, Makhdoom H. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet infectious diseases, 2013; 13(9): 752- 761 Phan L, Nguyen T, Luong Q, Nguyen T, Nguyen H, Le H, Pham Q. Importation, and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine, 2020; 382(9), 872-874 Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Zhang C. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology, 2020; 146(1): 110-118 Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 2020; 382(18): 1708-1720 He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Deng Y. Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 2006; 210(3): 288-297 Sheng W, Chiang B, Chang S, Ho H, Wang J, Chen Y, Yang P. Clinical manifestations, and inflammatory cytokine responses in patients with severe acute respiratory syndrome. Journal of the Formosan Medical Association= Taiwan yi zhi, 2005; 104(10): 715-723 Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, Gao Y. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 2020; 75(7): 1730-1741 Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, Song J. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 2020; 180(7): 934-943 Crackower M, Sarao R, Oudit G, Yagil C, Kozieradzki I, Scanga S, Scholey J. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature, 2002; 417(6891): 822-828 Lineamientos para el uso de pruebas diagnósticas para SARS-CoV-2 (COVID-19) en Colombia. Ministerio de salud y protección social. Marzo 2022 Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan 1;25(3) U.S. Department of Health & Human Services (2020) Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus. 24 Jan 2020. En: https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-fordetectioninstructions.pdf. 2014 Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clinica Chimica Acta, 2020; 505(1): 172-175 Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology, 2020; 200642 Thoracic S. Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (Trial version). Zhonghua jie he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases, 2020;43(3): 199 Trujillo C. Resumen: Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud. Infectio, 2020; 24(3): 1- 175 Villarroel P, Silva J, Atenas C, Pavez P. Evaluación del cuestionario SF-12: verificación de la utilidad de la escala salud mental. Rev Med Chile 2014; 142: 1275-1283 Urzúa A, Caqueo-Urízar A. Calidad de vida: Una revisión teórica del concepto. Ter Psicol 2012; 30 (1): 61-72 Rebollo P. Utilización del «grupo SF» de los cuestionarios de calidad de vida (SF-36, SF-12 y SF-6D) en el marco de ensayos clínicos y en la práctica clínica habitual. Med Clin (Barc) 2008; 130 (19): 740-1 Wölfel R, Corman V, Guggemos W, Seilmaier M, Zange S, Müller M, Hoelscher M. Virological assessment of hospitalized patients with COVID2019. Nature, 2020; 581(7809): 465-469 Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Qian S. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical Infectious Diseases, 2020; 71(16): 2027-2034 To K, Tsang O, Leung W, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565-574 Wu L, Wang N, Chang Y, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562-1564 Payne D, Iblan I, Rha B, et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016;22(10):1824-1826 Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. euro Surveill. 2020;25(10). doi:10.2807/1560-7917.ES.2020.25.10.2000191 Xiao A, Tong Y, Zhang S. False‐negative of RT‐PCR, and prolonged nucleic acid conversion in COVID‐19: rather than recurrence. Journal of medical virology, 2020; 92(10): 1755-1766 Young BE, Ong S, Kalimuddin S, et al; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients with SARS-CoV-2 in Singapore. JAMA. 2020;232(15):1488-1494 Kirkcaldy R, King B, Brooks J. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. Jama, 2020; 323(22): 2245-2246 Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection, 2020; 27(1): 89-95 Nalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stevens J, Wan y cols. Post-acute COVID-19 syndrome. Nature medicine, 2021; 1-15 Logue J, Franko N, McCulloch D, McDonald D, Magedson A, Wolf C, Chu H. Sequelae in adults at 6 months after COVID-19 infection. JAMA network open, 2021; 4(2): e210830-e210830 Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. Journal of medical virology, 2021; 93(2): 1013-1022 Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection, 2020; 81(6): e4-e6 Chopra V, Flanders S, O'Malley M, Malani A, Prescott H. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Annals of Internal Medicine, 2020:1-3 Martin-Villares C, Molina-Ramirez C, Bartolome-Benito M, Bernal-Sprekelsen M. Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain. European Archives of Oto-Rhino-Laryngology, 2021; 278(5): 1605-1612 Hosey M, Needham D. Survivorship after COVID-19 ICU stay. Nature reviews Disease primers, 2020; 6(1): 1-2 Inoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, Nishida O. Post‐intensive care syndrome: its pathophysiology, prevention, and future directions. Acute medicine & surgery, 2019; 6(3): 233-246 Herridge M, Tansey C, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Cheung A. Functional disability 5 years after acute respiratory distress syndrome. New England Journal of Medicine, 2011; 364(14): 1293-1304 Huppert L, Matthay M, Ware L. Pathogenesis of acute respiratory distress syndrome. In Seminars in respiratory and critical care medicine, 2019; 40(1): 31 Schaller T, Hirschbühl K, Burkhardt K, Braun G, Trepel M, Märkl B, Claus R. Postmortem examination of patients with COVID-19. Jama, 2020; 323(24): 2518-2520 De Michele S, Sun Y, Yilmaz M, Katsyv I, Salvatore M, Dzierba A, Saqi A. Forty Postmortem Examinations in COVID-19 Patients: Two Distinct Pathologic Phenotypes and Correlation with Clinical and Radiologic Findings. American journal of clinical pathology, 2020; 154(6): 748-760 Moodley Y, Scaffidi A, Misso N, Keerthisingam C, McAnulty R, Laurent G, Knight D. Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. The American journal of pathology, 2003; 163(1): 345-354 Bharat A, Querrey M, Markov N, Kim S, Kurihara C, Garza-Castillon R, Budinger G. Lung transplantation for patients with severe COVID-19. Science translational medicine, 2020; 12(574): eabe4282 Lang M, Som A, Mendoza D, Flores E, Reid N, Carey D, Little B. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. The Lancet Infectious Diseases, 2020; 20(12): 1365-1366 Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird W, Zwicker J. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood, The Journal of the American Society of Hematology, 2020; 136(11): 1342- 1346 Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri F. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. Journal of thrombosis and thrombolysis, 2020; 50(1): 281-286 Bikdeli, B., Madhavan, M. V., Gupta, A., Jimenez, D., Burton, J. R., Der Nigoghossian, C., ... & Group, T. C. (2020). Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thrombosis and haemostasis, 202; 120(7): 1004-1024 Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, BourbaoTournois C, Laribi S, Bernard L. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection, 2021; 27(2): 258-263 Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 2021; 397(10270): 220-232 Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, Westermann D. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA cardiology, 2020; 5(11): 1281- 1285 Siripanthong, B., Nazarian, S., Muser, D., Deo, R., Santangeli, P., Khanji, M. Y., ... & Chahal, C. A. A. (2020). Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart rhythm, 17(9), 1463-1471 Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, Chen H. Altered lipid metabolism in recovered SARS patients twelve years after infection. Scientific reports, 2017; 7(1): 1-12 Liu P, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation, 2020; 142(1): 68-78 Nordvig A, Fong K, Willey J, Thakur K, Boehme A, Vargas W, Elkind M. Potential neurologic manifestations of COVID-19. Neurology: Clinical Practice, 2021; 11(2): e135-e146 Bolay H, Gül A, Baykan B. COVID‐19 is a Real Headache! Headache: The Journal of Head and Face Pain, 2020; 60(7): 1415-1421 Pozo-Rosich, P. Headache & COVID-19: a short-term challenge with long-term insights. In Proc. AHSAM 2020 Virtual Annual Scientific Meeting (Infomedica, 2020); https://www.ahshighlights.com/ summariespodcasts/article/ headache-COVID-19-a-short- term-challenge-with- longterm-insights Kaseda E, Levine A. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. The Clinical Neuropsychologist, 2020; 34(7-8): 1498-1514 Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I. COVID19 BioB Outpatient Clinic Study group. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, behavior, and immunity, 2020; 89(1): 594-600 South K, McCulloch L, McColl B, Elkind M, Allan S, Smith C. Preceding infection, and risk of stroke: an old concept revived by the COVID-19 pandemic. International Journal of Stroke, 2020; 15(7): 722-732 Reichard R, Kashani K, Boire N, Constantopoulos E, Guo Y, Lucchinetti C. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta neuropathologica, 2020;140(1): 1-6 Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino C, Accardi G. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Frontiers in immunology, 2019; 10(1): 2247 Stevens J, King K, Robbins-Juarez S, Khairallah P, Toma K, Alvarado Verduzco H, Mohan S. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PloS one, 2020; 15(12): e0244131 Wilbers T, Koning M. Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery, and filter lifetime. Journal of Critical Care, 2020; 60(1): 103-105 Jhaveri K, Meir L, Chang B, Parikh R, Wanchoo R, Barilla-LaBarca M, Hajizadeh N. Thrombotic microangiopathy in a patient with COVID-19. Kidney international, 2020; 98(2): 509-512 Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID‐19: Causality or coincidence? A report of three cases. Journal of medical virology, 2021; 93(2): 1150-1153 Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID19. Journal of Endocrinological Investigation, 2020; 43(10): 1527-1528 Salvio G, Gianfelice C, Firmani F, Lunetti S, Balercia G, Giacchetti G. Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications. Clinical Reviews in Bone and Mineral Metabolism, 2020; 1-7 Arnold D, Hamilton F, Milne A, Morley A, Viner J, Attwood M, Barratt S. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax, 2021; 76(4): 399-401 Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, Gong S. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature medicine, 2020; 26(4): 502-505 Zeppa S, Agostini D, Piccoli G, Stocchi V, Sestili P. Gut Microbiota Status in COVID-19: An Unrecognized Player? Frontiers in cellular and infection microbiology; 2020, 10:1-10 Bradley K, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Wack A. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell reports, 2019; 28(1): 245-256 Miquel S, Martin R, Rossi O, Bermudez-Humaran L, Chatel J, Sokol H, Langella P. Faecalibacterium prausnitzii and human intestinal health. Current opinion in microbiology, 2013; 16(3): 255-261 Freeman E, McMahon D, Lipoff J, Rosenbach M, Kovarik C, Desai S, Fox L. The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries. Journal of the American Academy of Dermatology, 2020; 83(4): 1118-1129 Mirza F, Malik A, Omer S, Sethi A. Dermatologic manifestations of COVID‐19: a comprehensive systematic review. International journal of dermatology, 2021; 60(4): 418-450 Genovese G, Moltrasio C, Berti E, Marzano A. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology, 2020; 237(1): 1-12 Vilagut G, Valderas J, Ferrer M, Garin O, López-García E, Alonso J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Medicina clínica, 2008; 130(19): 726-735 Gupta A, Madhavan M, Sehgal K, Nair N, Mahajan S, Sehrawat T, Landry D. Extrapulmonary manifestations of COVID-19. Nature medicine, 2020; 26(7): 1017-1032 Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. Jama, 2020; 324(6): 603-605 Pettrone K, Burnett E, Link-Gelles R, Haight S, Schrodt C, England L, Killerby M. Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March–April 2020. Emerging infectious diseases, 2021; 27(4): 1164 McElvaney O, McEvoy N, McElvaney O, Carroll T, Murphy M, Dunlea D, McElvaney N. Characterization of the inflammatory response to severe COVID-19 illness. American journal of respiratory and critical care medicine, 2020; 202(6): 812-821 Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, Merle U. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clinical infectious diseases, 2022; 74(7): 1191-1198 Logue J, Franko N, McCulloch D, McDonald D, Magedson A, Wolf C, Chu H. Sequelae in adults at 6 months after COVID-19 infection. JAMA network open, 2021; 4(2): e210830-e210830 Talman S, Boonman-de Winter L, De Mol M, Hoefman E, Van Etten R, De Backer I. Pulmonary function and health-related quality of life after COVID19 pneumonia. Respiratory Medicine, 2021; 176(1): 106272 Vaes A, Goërtz Y, Van Herck M, Machado F, Meys R, Delbressine J, Spruit M. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ open research, 2021; 7(2): 2345 Vlake J, Wesselius S, van Genderen M, van Bommel J, Boxma-de Klerk B, Wils E. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study. PloS one, 2021; 16(8): e0255774 Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R, Steves C. Attributes and predictors of long COVID. Nature medicine, 2021; 27(4): 626-631 |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
| dc.rights.license.*.fl_str_mv |
Atribución-NoComercial-SinDerivadas 2.5 Colombia |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ Atribución-NoComercial-SinDerivadas 2.5 Colombia http://purl.org/coar/access_right/c_abf2 |
| dc.format.spa.fl_str_mv |
PDF |
| dc.coverage.spatial.spa.fl_str_mv |
Barranquilla |
| institution |
Universidad Libre |
| bitstream.url.fl_str_mv |
http://repository.unilibre.edu.co/bitstream/10901/23839/3/CASTELL%c3%93N%20DE%20LA%20ROSA.pdf.jpg http://repository.unilibre.edu.co/bitstream/10901/23839/2/license.txt http://repository.unilibre.edu.co/bitstream/10901/23839/1/CASTELL%c3%93N%20DE%20LA%20ROSA.pdf |
| bitstream.checksum.fl_str_mv |
de42cf5dc6bc6f1922422fc6546076df 8a4605be74aa9ea9d79846c1fba20a33 03588852ccf9db9980987afd91555afb |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional Unilibre |
| repository.mail.fl_str_mv |
repositorio@unilibrebog.edu.co |
| _version_ |
1814090520199168000 |
| spelling |
Zuluaga De León, IvánNavarro Baene, GinaCastellón De La Rosa, Evis AdrianaJiménez Arcia, Luisa FernandaBarranquilla2022-12-05T20:27:53Z2022-12-05T20:27:53Z2022https://hdl.handle.net/10901/23839OBJETIVO GENERAL Determinar las manifestaciones clínicas posagudas y nivel de calidad de vida a 6 meses en pacientes atendidos por COVID-19 en el Hospital General de Barranquilla, durante el periodo de enero a julio de 2021. METODOLOGÍA Estudio descriptivo, longitudinal, prospectivo. Los datos fueron obtenidos del Hospital General de Barranquilla y el seguimiento a 6 meses se realiza— por vía telefónica mediante encuesta de síntomas y escala SF12. El análisis se hizo mediante el programa SPSS en su versión 15. Se emplearon medidas descriptivas para el análisis univariado: porcentaje y promedio y desviación estándar. Para el análisis bivariado se emplea— prueba t.Ê RESULTADOS De 16 manifestaciones clínicas postagudas descritas en la literatura, la disnea y la fatiga, fueron las más frecuentes, con 42,2% y 41,3%, respectivamente, el resto de las manifestaciones estuvieron entre 13,9% y 28,3%. El resultado de los componentes de salud física y salud mental, según el SF-12, muestran que, en ninguno de los casos el promedio llega a 50 puntos, siendo más bajo para salud física (Prom: 38,1 +/-5,5). ??Al comparar los promedios de salud física y emocional según las variables sociodemográficas, se encontraron diferencias significativas (p<0,05) para el sexo (mayor puntaje en hombres) en salud física y para el estrato (mayor puntaje en el estrato dos) en salud mental. Al relacionar los promedios de las dimensiones salud física y salud mental según cada una de las manifestaciones clínicas postagudas, no se encontraron diferencias significativas en ninguno de los casos, con excepción—n del dolor torácico en la primera dimensión. CONCLUSIONES La dificultad respiratoria y la fatiga fueron las manifestaciones más frecuentes. Los puntajes del SF-12 tanto para el componente de salud física como para el de salud mental fueron relativamente bajos en la mayoría de los participantes, por lo que solamente se encontraron diferencias significativas al cruzar salud física con sexo y salud mental con estrato socioeconómico, para el caso de las variables sociodemográficas. Para las manifestaciones clínicas postagudas no hubo diferencias significativas entre los que las padecían y los que no.Universidad Libre Seccional Barranquilla -- Facultad de Ciencias de la Salud -- Especialización en Medicina InternaGENERAL OBJECTIVE To determine the post-acute clinical manifestations and level of quality of life at 6 months in patients treated for COVID-19 at the General Hospital of Barranquilla, during the period from January to July 2021. METHODOLOGY Descriptive, longitudinal, prospective study. The data were obtained from the General Hospital of Barranquilla and the 6-month follow-up was carried out by telephone using a symptom survey and the SF12 scale. The analysis was done using the SPSS program in its version 15. Descriptive measures were used for the univariate analysis: percentage and mean and standard deviation. For the bivariate analysis, a t-test was used. RESULTS Of 16 post-acute clinical manifestations described in the literature, dyspnea and fatigue were the most frequent, with 42.2% and 41.3%, respectively, the rest of the manifestations appeared between 13.9% and 28.3%. The result of the physical health and mental health components, according to the SF-12, shows that, in none of the cases, the average reached 50 points, being lower for physical health (Average: 38.1 +/-5,5). When comparing the averages of physical and emotional health according to the sociodemographic variables, significant differences (p<0.05) were found for gender (higher score in men) in physical health and for the stratum (higher score in stratum two) in mental health. When relating the averages of the physical health and mental health dimensions according to each of the post-acute clinical manifestations, no significant differences were found in any of the cases, except for chest pain in the first dimension. CONCLUSIONS Respiratory distress and fatigue were the most frequent manifestations. The SF-12 scores for both the physical health and mental health components were relatively low in most of the participants, so significant differences were only found when crossing physical health with gender and mental health with socioeconomic status. for the case of sociodemographic variables. For post-acute clinical manifestations, there were no significant differences between those who suffered from them and those who did not.PDFhttp://creativecommons.org/licenses/by-nc-nd/2.5/co/Atribución-NoComercial-SinDerivadas 2.5 Colombiahttp://purl.org/coar/access_right/c_abf2COVID 19Manifestaciones posagudasCalidad de vidaFactores de riesgoCOVID 19Post-acute manifestationsQuality of lifeRisk factorsInfecciones por coronavirusCalidad de vidaSignos y síntomasManifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021Tesis de Especializacióninfo:eu-repo/semantics/bachelorThesishttp://purl.org/coar/resource_type/c_7a1fWho.int (Internet). Estados Unidos: Whoint; 2000 [actualizado 06 de noviembre 2020; citado 1 de noviembre de 2020. Tomado de: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public Fecha de acceso: febrero de 2021Coronavirus.jhu.edu. Estados Unidos: coronavirus.jhu.edu; 2020. Tomado de: https://coronavirus.jhu.edu/map.html Fecha de acceso: febrero de 2021Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of postacute COVID-19 in primary care. BMJ. 2020;370:m3026Del Rio C, Collins L, Malani P. Long-term health consequences of COVID19. Jama, 2020; 324(17): 1723-1724Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, Zhou X et al. Impact of Coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020; 21:163Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID -19. JAMA. 2020; 324(6):603-605Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. The Lancet, 2020; 395(10224): e37-e38Xu Z, Li S, Tian S, Li H, Kong L. Full spectrum of COVID-19 severity still being depicted. Lancet, 2020; 395(10228): 947Jack A. Why the panic? South Korea’s MERS response questioned. Bmj, 2015; 350(1): h3403Abdel-Moneim A. Middle East respiratory syndrome coronavirus: Is it worth a world panic? World journal of virology, 2015; 4(3): 185-187Brooks S, Webster R, Smith L, Woodland L, Wessely S, Greenberg N, Rubin G. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet, 2020; 395(10227): P912-P920Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-Related Quality of Life and its Associated Factors in. COVID-19 Patients. Osong Public Health Res Perspect 2020;11(5):296-302Piedra J, Cuellar C, Machado V. Instrumentos evaluadores de secuelas en pacientes postinfección a COVID-19. Su utilidad en rehabilitación. Revista Cubana de Medicina Física y Rehabilitación, 2020; 12(3): 1-22Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay, 2020; 10(2): 78-88Maley J, Brewster I, Mayoral I, Siruckova R, Adams S, McGraw K, Mikkelsen M. Resilience in survivors of critical illness in the context of the survivors’ experience and recovery. Ann Am Thorac Soc. 2016;13(8):1351-1360Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA, 2020;324(6):603-605Tenforde M, Kim S, Lindsell C y cols.; IVY Network Investigators; CDC COVID19 Response Team; IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network: United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998Caliari D, Campos K, Dos Santos P, Louro S, Curty T, Mendanha T, Dos Reis E. Associação entre las características sociodemográficas y síntomas da COVID-19 em pacientes residentes do Espírito Santo, Brasil: Association between the sociodemographic characteristics and COVID-19 symptoms in patients resident in Espírito Santo state, Brazil. Health and Biosciences, 2020; 1(2): 32-51Instituto Nacional de Salud. Coronavirus. Tomado de: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx Fecha de acceso: febrero de 2021Rothan H, Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity, 2020; 109(1): 102433Puntmann V, Carerj M, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3557Rajpal S, Tong M, Borchers J, Zareba K, Obarski T, Simonetti O, Daniels C. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA cardiology, 2021; 6(1): 116-118Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, Luo H. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine, 2020; 25(1): 100463Zubair A, McAlpine L, Gardin T, Farhadian S, Kuruvilla D, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018-1027Galea S, Merchant R, Lurie N. The mental health consequences of COVID19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020;180(6):817-818Ware J, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical care, 1996; 34(1): 220-233Cleaton N, Raizada S, Barkham N, Venkatachalam S, Sheeran T, Adizie T, Bateman J. COVID-19 prevalence and the impact on quality of life from stringent social distancing in a single large UK rheumatology centre. Annals of the Rheumatic Diseases, 2021; 80(6): e93-e93Liu C, Stevens C, Conrad R, Hahm H. Evidence for elevated psychiatric distress, poor sleep, and quality of life concerns during the COVID-19 pandemic among US young adults with suspected and reported psychiatric diagnoses. Psychiatry research, 2020; 292(1): 113345Di Stefano V, Battaglia G, Giustino V, Gagliardo A, D’Aleo M, Giannini O, Brighina F. Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine. Journal of neurology, 2020; 1(1): 1-7Walline J. COVID -19- Quality of Life After Infection. Clinical Trials. gov: NCT04377464. Chinese University of Hong Kong. 2020. disponible en https://clinicaltrials.gov/ct2/show/NCT04377464#contactsSaavedra C, Buitrago A, Jiménez A, Mejía A, Narváez A, Rojas A, et al. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud. Infectio. 2020; 24 (3):1-153Maréchal M, Morand P, Epaulard O, Némoz B. COVID-19 in clinical practice: a narrative synthesis. Med Mal Infect, 2020; 50(20): 30710-1Gordon D, Jang G, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARSCoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; 583Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020;2Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181:271-280.e8Chan J, Yuan S, Kok K, Wang K, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. Lancet. 2020; 395: 514–23Lei J, Li J, Li X, Qi X. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 2020; 295(1): 18-18Lu H. Drug treatment options for the 2019-new coronavirus (2019- nCoV). Bioscience trends, 2020;14(1): 69-71Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020; 395(10223): 497-506Luo W, Yu H, Gou J, Li X, Sun Y, Li J, Liu L. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints, 2020: 2020020407Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon D, Van Tassell B, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nature Reviews Immunology, 2021; 21(5): 319- 329Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Xing X. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 2020; 382(1):1199-1207Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol, 2020; 92(4): 441– 447Carlos W, Dela Cruz C, Cao B, Pasnick S, Jamil S. Novel wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med, 2020; 201(4): 7–8Assiri A, Al-Tawfiq J, Al-Rabeeah A, Al-Rabiah F, Al-Hajjar S, Al-Barrak A, Makhdoom H. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet infectious diseases, 2013; 13(9): 752- 761Phan L, Nguyen T, Luong Q, Nguyen T, Nguyen H, Le H, Pham Q. Importation, and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine, 2020; 382(9), 872-874Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Zhang C. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology, 2020; 146(1): 110-118Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 2020; 382(18): 1708-1720He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Deng Y. Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 2006; 210(3): 288-297Sheng W, Chiang B, Chang S, Ho H, Wang J, Chen Y, Yang P. Clinical manifestations, and inflammatory cytokine responses in patients with severe acute respiratory syndrome. Journal of the Formosan Medical Association= Taiwan yi zhi, 2005; 104(10): 715-723Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, Gao Y. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 2020; 75(7): 1730-1741Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, Song J. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 2020; 180(7): 934-943Crackower M, Sarao R, Oudit G, Yagil C, Kozieradzki I, Scanga S, Scholey J. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature, 2002; 417(6891): 822-828Lineamientos para el uso de pruebas diagnósticas para SARS-CoV-2 (COVID-19) en Colombia. Ministerio de salud y protección social. Marzo 2022Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan 1;25(3)U.S. Department of Health & Human Services (2020) Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus. 24 Jan 2020. En: https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-fordetectioninstructions.pdf. 2014Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clinica Chimica Acta, 2020; 505(1): 172-175Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology, 2020; 200642Thoracic S. Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (Trial version). Zhonghua jie he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases, 2020;43(3): 199Trujillo C. Resumen: Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud. Infectio, 2020; 24(3): 1- 175Villarroel P, Silva J, Atenas C, Pavez P. Evaluación del cuestionario SF-12: verificación de la utilidad de la escala salud mental. Rev Med Chile 2014; 142: 1275-1283Urzúa A, Caqueo-Urízar A. Calidad de vida: Una revisión teórica del concepto. Ter Psicol 2012; 30 (1): 61-72Rebollo P. Utilización del «grupo SF» de los cuestionarios de calidad de vida (SF-36, SF-12 y SF-6D) en el marco de ensayos clínicos y en la práctica clínica habitual. Med Clin (Barc) 2008; 130 (19): 740-1Wölfel R, Corman V, Guggemos W, Seilmaier M, Zange S, Müller M, Hoelscher M. Virological assessment of hospitalized patients with COVID2019. Nature, 2020; 581(7809): 465-469Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Qian S. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical Infectious Diseases, 2020; 71(16): 2027-2034To K, Tsang O, Leung W, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565-574Wu L, Wang N, Chang Y, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562-1564Payne D, Iblan I, Rha B, et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016;22(10):1824-1826Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. euro Surveill. 2020;25(10). doi:10.2807/1560-7917.ES.2020.25.10.2000191Xiao A, Tong Y, Zhang S. False‐negative of RT‐PCR, and prolonged nucleic acid conversion in COVID‐19: rather than recurrence. Journal of medical virology, 2020; 92(10): 1755-1766Young BE, Ong S, Kalimuddin S, et al; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients with SARS-CoV-2 in Singapore. JAMA. 2020;232(15):1488-1494Kirkcaldy R, King B, Brooks J. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. Jama, 2020; 323(22): 2245-2246Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection, 2020; 27(1): 89-95Nalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stevens J, Wan y cols. Post-acute COVID-19 syndrome. Nature medicine, 2021; 1-15Logue J, Franko N, McCulloch D, McDonald D, Magedson A, Wolf C, Chu H. Sequelae in adults at 6 months after COVID-19 infection. JAMA network open, 2021; 4(2): e210830-e210830Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. Journal of medical virology, 2021; 93(2): 1013-1022Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection, 2020; 81(6): e4-e6Chopra V, Flanders S, O'Malley M, Malani A, Prescott H. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Annals of Internal Medicine, 2020:1-3Martin-Villares C, Molina-Ramirez C, Bartolome-Benito M, Bernal-Sprekelsen M. Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain. European Archives of Oto-Rhino-Laryngology, 2021; 278(5): 1605-1612Hosey M, Needham D. Survivorship after COVID-19 ICU stay. Nature reviews Disease primers, 2020; 6(1): 1-2Inoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, Nishida O. Post‐intensive care syndrome: its pathophysiology, prevention, and future directions. Acute medicine & surgery, 2019; 6(3): 233-246Herridge M, Tansey C, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Cheung A. Functional disability 5 years after acute respiratory distress syndrome. New England Journal of Medicine, 2011; 364(14): 1293-1304Huppert L, Matthay M, Ware L. Pathogenesis of acute respiratory distress syndrome. In Seminars in respiratory and critical care medicine, 2019; 40(1): 31Schaller T, Hirschbühl K, Burkhardt K, Braun G, Trepel M, Märkl B, Claus R. Postmortem examination of patients with COVID-19. Jama, 2020; 323(24): 2518-2520De Michele S, Sun Y, Yilmaz M, Katsyv I, Salvatore M, Dzierba A, Saqi A. Forty Postmortem Examinations in COVID-19 Patients: Two Distinct Pathologic Phenotypes and Correlation with Clinical and Radiologic Findings. American journal of clinical pathology, 2020; 154(6): 748-760Moodley Y, Scaffidi A, Misso N, Keerthisingam C, McAnulty R, Laurent G, Knight D. Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. The American journal of pathology, 2003; 163(1): 345-354Bharat A, Querrey M, Markov N, Kim S, Kurihara C, Garza-Castillon R, Budinger G. Lung transplantation for patients with severe COVID-19. Science translational medicine, 2020; 12(574): eabe4282Lang M, Som A, Mendoza D, Flores E, Reid N, Carey D, Little B. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. The Lancet Infectious Diseases, 2020; 20(12): 1365-1366Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird W, Zwicker J. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood, The Journal of the American Society of Hematology, 2020; 136(11): 1342- 1346Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri F. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. Journal of thrombosis and thrombolysis, 2020; 50(1): 281-286Bikdeli, B., Madhavan, M. V., Gupta, A., Jimenez, D., Burton, J. R., Der Nigoghossian, C., ... & Group, T. C. (2020). Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thrombosis and haemostasis, 202; 120(7): 1004-1024Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, BourbaoTournois C, Laribi S, Bernard L. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection, 2021; 27(2): 258-263Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 2021; 397(10270): 220-232Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, Westermann D. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA cardiology, 2020; 5(11): 1281- 1285Siripanthong, B., Nazarian, S., Muser, D., Deo, R., Santangeli, P., Khanji, M. Y., ... & Chahal, C. A. A. (2020). Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart rhythm, 17(9), 1463-1471Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, Chen H. Altered lipid metabolism in recovered SARS patients twelve years after infection. Scientific reports, 2017; 7(1): 1-12Liu P, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation, 2020; 142(1): 68-78Nordvig A, Fong K, Willey J, Thakur K, Boehme A, Vargas W, Elkind M. Potential neurologic manifestations of COVID-19. Neurology: Clinical Practice, 2021; 11(2): e135-e146Bolay H, Gül A, Baykan B. COVID‐19 is a Real Headache! Headache: The Journal of Head and Face Pain, 2020; 60(7): 1415-1421Pozo-Rosich, P. Headache & COVID-19: a short-term challenge with long-term insights. In Proc. AHSAM 2020 Virtual Annual Scientific Meeting (Infomedica, 2020); https://www.ahshighlights.com/ summariespodcasts/article/ headache-COVID-19-a-short- term-challenge-with- longterm-insightsKaseda E, Levine A. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. The Clinical Neuropsychologist, 2020; 34(7-8): 1498-1514Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I. COVID19 BioB Outpatient Clinic Study group. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, behavior, and immunity, 2020; 89(1): 594-600South K, McCulloch L, McColl B, Elkind M, Allan S, Smith C. Preceding infection, and risk of stroke: an old concept revived by the COVID-19 pandemic. International Journal of Stroke, 2020; 15(7): 722-732Reichard R, Kashani K, Boire N, Constantopoulos E, Guo Y, Lucchinetti C. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta neuropathologica, 2020;140(1): 1-6Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino C, Accardi G. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Frontiers in immunology, 2019; 10(1): 2247Stevens J, King K, Robbins-Juarez S, Khairallah P, Toma K, Alvarado Verduzco H, Mohan S. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PloS one, 2020; 15(12): e0244131Wilbers T, Koning M. Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery, and filter lifetime. Journal of Critical Care, 2020; 60(1): 103-105Jhaveri K, Meir L, Chang B, Parikh R, Wanchoo R, Barilla-LaBarca M, Hajizadeh N. Thrombotic microangiopathy in a patient with COVID-19. Kidney international, 2020; 98(2): 509-512Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID‐19: Causality or coincidence? A report of three cases. Journal of medical virology, 2021; 93(2): 1150-1153Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID19. Journal of Endocrinological Investigation, 2020; 43(10): 1527-1528Salvio G, Gianfelice C, Firmani F, Lunetti S, Balercia G, Giacchetti G. Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications. Clinical Reviews in Bone and Mineral Metabolism, 2020; 1-7Arnold D, Hamilton F, Milne A, Morley A, Viner J, Attwood M, Barratt S. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax, 2021; 76(4): 399-401Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, Gong S. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature medicine, 2020; 26(4): 502-505Zeppa S, Agostini D, Piccoli G, Stocchi V, Sestili P. Gut Microbiota Status in COVID-19: An Unrecognized Player? Frontiers in cellular and infection microbiology; 2020, 10:1-10Bradley K, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Wack A. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell reports, 2019; 28(1): 245-256Miquel S, Martin R, Rossi O, Bermudez-Humaran L, Chatel J, Sokol H, Langella P. Faecalibacterium prausnitzii and human intestinal health. Current opinion in microbiology, 2013; 16(3): 255-261Freeman E, McMahon D, Lipoff J, Rosenbach M, Kovarik C, Desai S, Fox L. The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries. Journal of the American Academy of Dermatology, 2020; 83(4): 1118-1129Mirza F, Malik A, Omer S, Sethi A. Dermatologic manifestations of COVID‐19: a comprehensive systematic review. International journal of dermatology, 2021; 60(4): 418-450Genovese G, Moltrasio C, Berti E, Marzano A. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology, 2020; 237(1): 1-12Vilagut G, Valderas J, Ferrer M, Garin O, López-García E, Alonso J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Medicina clínica, 2008; 130(19): 726-735Gupta A, Madhavan M, Sehgal K, Nair N, Mahajan S, Sehrawat T, Landry D. Extrapulmonary manifestations of COVID-19. Nature medicine, 2020; 26(7): 1017-1032Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. Jama, 2020; 324(6): 603-605Pettrone K, Burnett E, Link-Gelles R, Haight S, Schrodt C, England L, Killerby M. Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March–April 2020. Emerging infectious diseases, 2021; 27(4): 1164McElvaney O, McEvoy N, McElvaney O, Carroll T, Murphy M, Dunlea D, McElvaney N. Characterization of the inflammatory response to severe COVID-19 illness. American journal of respiratory and critical care medicine, 2020; 202(6): 812-821Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, Merle U. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clinical infectious diseases, 2022; 74(7): 1191-1198Logue J, Franko N, McCulloch D, McDonald D, Magedson A, Wolf C, Chu H. Sequelae in adults at 6 months after COVID-19 infection. JAMA network open, 2021; 4(2): e210830-e210830Talman S, Boonman-de Winter L, De Mol M, Hoefman E, Van Etten R, De Backer I. Pulmonary function and health-related quality of life after COVID19 pneumonia. Respiratory Medicine, 2021; 176(1): 106272Vaes A, Goërtz Y, Van Herck M, Machado F, Meys R, Delbressine J, Spruit M. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ open research, 2021; 7(2): 2345Vlake J, Wesselius S, van Genderen M, van Bommel J, Boxma-de Klerk B, Wils E. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study. PloS one, 2021; 16(8): e0255774Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R, Steves C. Attributes and predictors of long COVID. Nature medicine, 2021; 27(4): 626-631THUMBNAILCASTELLÓN DE LA ROSA.pdf.jpgCASTELLÓN DE LA ROSA.pdf.jpgIM Thumbnailimage/jpeg16317http://repository.unilibre.edu.co/bitstream/10901/23839/3/CASTELL%c3%93N%20DE%20LA%20ROSA.pdf.jpgde42cf5dc6bc6f1922422fc6546076dfMD53LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repository.unilibre.edu.co/bitstream/10901/23839/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52ORIGINALCASTELLÓN DE LA ROSA.pdfCASTELLÓN DE LA ROSA.pdfapplication/pdf1380510http://repository.unilibre.edu.co/bitstream/10901/23839/1/CASTELL%c3%93N%20DE%20LA%20ROSA.pdf03588852ccf9db9980987afd91555afbMD5110901/23839oai:repository.unilibre.edu.co:10901/238392023-08-03 11:48:56.773Repositorio Institucional Unilibrerepositorio@unilibrebog.edu.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 |